Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by toinv261on May 10, 2017 12:19pm
111 Views
Post# 26226296

RE:RE:RE:RE:RE:RE:Kumbaya.......

RE:RE:RE:RE:RE:RE:Kumbaya.......Thanks fuzzy.

"U & led thinking your so much more valuable to the board than others is completely ridiculous."
Read more at https://www.stockhouse.com/companies/bullboard/t.rvx/resverlogix-corp?postid=26225873#W5pyhYIBWMDFAoi1.99

I certainly do not think that I provide any value. As I stated, I'm just thinking out loud and I do not have an ego and I know I don't provide great insights.

Anyway, I should never have gotten sucked into this but I let my guard down.

BigDolphin, you make a good point...it is binary. At the end of the day it is all about getting past the futility analysis and then waiting until the end of 2018 and even then it is a few years to market. That is unless suitors move in or the next regional deal gives us a new picture. I will certainly not repeat all of the other potential positive things that can happen in the interim.

BigD there are many positive experiences to have in life. I would recommend for your own mental well being that you go away and enjoy good things and perhaps you should stop reading posts. I also recommend that you and fuzzy just stick to reading the RVX and Zenith websites. You will both be happier.

I sincerely wish everyone good luck. We are all in this to win.

I was going to ask if anyone has trading strategies leading up to the futility analysis?

Finally, I won't do these types of posts again.

GLTA
Cheers
Toinv
Bullboard Posts